Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
about
Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined RoutingNon-metallic nanomaterials in cancer theranostics: a review of silica- and carbon-based drug delivery systemsEncapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice.Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlookTarget-selective delivery and activation of platinum-based anticancer agents.Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.Nanoparticle formulations of cisplatin for cancer therapy.Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications.pH-Responsive Mesoporous Silica and Carbon Nanoparticles for Drug Delivery.Engineering cytochrome-modified silica nanoparticles to induce programmed cell death.Large-Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum-Acridine Anticancer Agent.The autophagic inhibition oral squamous cell carcinoma cancer growth of 16-hydroxy-cleroda-3,14-dine-15,16-olide.Facile synthesis of highly biocompatible folic acid-functionalised SiO2 nanoparticles encapsulating rare-earth metal complexes, and their application in targeted drug delivery.Phosphatase-triggered cell-selective release of a Pt(iv)-backboned prodrug-like polymer for an improved therapeutic index.Silicon-based nanotheranostics.Mesoporous Silica Nanoparticles for Drug Delivery and Controlled Release ApplicationsMesoporous-Silica-Functionalized Nanoparticles for Drug Delivery
P2860
Q26746171-BD9EF092-A7A1-4A4A-98E2-05EDB1C77439Q28822460-6B710DBF-AAA9-4071-9CE3-C1E2FAD3C2CEQ33742245-5C0C7E5F-8307-43ED-ADDA-ACFF6AA9F2D0Q37538055-768B80F2-D291-465D-860D-641FE00461EEQ38523600-A699C56A-B2FB-4DF2-8487-0C1C93B5A5D9Q38563960-A8A0F3EE-FCC4-458F-9473-2D3A23B29258Q38723829-FC1B0ABF-B97C-46F6-A522-91CCCFE33608Q39297820-368D6939-92A3-4A0E-9047-C5F428F07AFFQ41512962-00D25EF0-1C9E-4FC7-9847-5EEDFE9BC5CFQ42097977-9E969294-60CF-4AC5-A126-C5FA8B24EA54Q44869674-42D72526-5320-4406-9598-7349BB812338Q45395327-301B7767-8EA2-4E07-9ABD-FD04F7104DABQ47821565-833C9F43-3160-4639-8EBA-2F368CB12301Q48258055-B9D27C89-ACB3-4C32-9CF9-ECA43FAC9188Q50275652-BA0ED2A2-C096-474A-A27E-73688249E7BDQ57341237-81CD2617-6B67-43B2-9002-1A1488660B23Q57342490-E6B688FC-4E3E-4C05-82E2-0692263731DE
P2860
Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
@en
Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
@nl
type
label
Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
@en
Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
@nl
prefLabel
Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
@en
Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
@nl
P2093
P1476
Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
@en
P2093
Chia-Hui Lin
Chia-Hung Lee
Ching-Feng Weng
Pei-Ru Wei
Ping-Jyun Sung
Shih-Hsun Cheng
Wei-Neng Liao
P304
P356
10.1016/J.IJPHARM.2012.03.026
P407
P577
2012-03-23T00:00:00Z